Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
暂无分享,去创建一个
Phichayut Phinyo | C. Angkurawaranon | K. Pinyopornpanish | W. Jiraporncharoen | N. Buawangpong | A. Soontornpun | Kanokporn Pinyopornpanish | Atiwat Soontornpun
[1] Á. Alonso,et al. Associations of Atrial Fibrillation with Mild Cognitive Impairment and Dementia: An Investigation Using SPRINT Research Materials , 2022, Journal of clinical medicine.
[2] H. Hagström,et al. Nonalcoholic Fatty Liver Disease and Risk of Dementia , 2022, Neurology.
[3] D. Giunta,et al. [Mortality in patients with dementia admitted in critical care units]. , 2022, Revista espanola de geriatria y gerontologia.
[4] Sang Min Park,et al. Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults , 2022, Clinical and molecular hepatology.
[5] Spiros C. Denaxas,et al. Incidence, morbidity, mortality and disparities in dementia: A population linked electronic health records study of 4.3 million individuals , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[6] I. Oh,et al. Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study , 2022, Liver international : official journal of the International Association for the Study of the Liver.
[7] C. Suemoto,et al. Accuracy of two prognostic indexes to predict mortality in older adults with advanced dementia , 2022, Dementia & neuropsychologia.
[8] E. Kang,et al. Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-Based Cohort Study. , 2022, The Journal of clinical endocrinology and metabolism.
[9] Yongliang Gao,et al. Secular Trends in the Incidence of and Mortality Due to Alzheimer’s Disease and Other Forms of Dementia in China From 1990 to 2019: An Age-Period-Cohort Study and Joinpoint Analysis , 2021, Frontiers in Aging Neuroscience.
[10] Wenli Zhang,et al. Relationship between multimorbidity, disease cluster and all-cause mortality among older adults: a retrospective cohort analysis , 2021, BMC Public Health.
[11] B. Winblad,et al. Mortality After Ischemic Stroke in Patients with Alzheimer’s Disease Dementia and Other Dementia Disorders , 2021, Journal of Alzheimer's disease : JAD.
[12] H. Brodaty,et al. Dementia increases mortality beyond effects of comorbid conditions: A national registry‐based cohort study , 2021, European journal of neurology.
[13] Kankamol Jaisin,et al. Etiology of Dementia in Thai Patients , 2021, Dementia and Geriatric Cognitive Disorders Extra.
[14] I. Hadžibegović,et al. Patients with dementia and atrial fibrillation less frequently receive direct oral anticoagulants (DOACs) and experience higher thrombotic and mortality risk , 2021, Acta clinica Belgica.
[15] S. Hartikainen,et al. The effect of comorbidities on survival in persons with Alzheimer’s disease: a matched cohort study , 2021, BMC Geriatrics.
[16] R. Stewart,et al. Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis. , 2021, The Lancet. Healthy longevity.
[17] Jose A. Santiago,et al. The Impact of Disease Comorbidities in Alzheimer's Disease , 2021, Frontiers in Aging Neuroscience.
[18] Tanyaluk O. Bunlikitkul,et al. Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study , 2021, International journal of cardiology. Heart & vasculature.
[19] B. Winblad,et al. Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study , 2020, Journal of internal medicine.
[20] M. Prince,et al. Mortality Rates and Mortality Risk Factors in Older Adults with Dementia from Low- and Middle-Income Countries: The 10/66 Dementia Research Group Population-Based Cohort Study , 2020, Journal of Alzheimer's disease : JAD.
[21] L. Tan,et al. The Prevalence of Dementia: A Systematic Review and Meta-Analysis. , 2019, Journal of Alzheimer's disease : JAD.
[22] Ming-Chin Lin,et al. Association Between Atrial Fibrillation and Dementia: A Meta-Analysis , 2019, Front. Aging Neurosci..
[23] David A Bennett,et al. Diagnosis and Management of Dementia: Review. , 2019, JAMA.
[24] J. Vilalta-Franch,et al. Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study , 2019, Clinical epidemiology.
[25] Ming-Tsang Wu,et al. Association of hyperglycemia episodes on long-term mortality in type 2 diabetes mellitus with vascular dementia: A population-based cohort study. , 2019, Journal of diabetes and its complications.
[26] L. Schneider,et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need , 2018, Alzheimer's & Dementia.
[27] O. Sinanović,et al. Communication Difficulties as a Result of Dementia , 2018, Materia socio-medica.
[28] G. Selbæk,et al. Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway , 2018, PloS one.
[29] C. Muo,et al. Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study , 2018, PloS one.
[30] R. Howard,et al. Diagnosed depression and sociodemographic factors as predictors of mortality in patients with dementia , 2018, The British journal of psychiatry : the journal of mental science.
[31] Mostafa Rezaei-Tavirani,et al. Protein-protein interaction analysis of Alzheimer`s disease and NAFLD based on systems biology methods unhide common ancestor pathways , 2018, Gastroenterology and hepatology from bed to bench.
[32] J. Hardy,et al. Alzheimer's disease , 2018, European journal of neurology.
[33] E. Kang,et al. Impact of diabetes mellitus and chronic liver disease on the incidence of dementia and all-cause mortality among patients with dementia , 2017, Medicine.
[34] Tyler J. VanderWeele,et al. Sensitivity Analysis in Observational Research: Introducing the E-Value , 2017, Annals of Internal Medicine.
[35] Pei-Ning Wang,et al. Comorbidity and dementia: A nationwide survey in Taiwan , 2017, PloS one.
[36] David C. Atkins,et al. Dementia and co‐occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence? , 2017, International journal of geriatric psychiatry.
[37] R. Weinstock,et al. Management of Adults With Diabetes and Cognitive Problems , 2016, Diabetes Spectrum.
[38] M. Prince,et al. Recent global trends in the prevalence and incidence of dementia, and survival with dementia , 2016, Alzheimer's Research & Therapy.
[39] Leon E. Toussaint,et al. Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model , 2016, Journal of Neuroinflammation.
[40] J. Reitsma,et al. Effect of Vascular Risk Factors and Diseases on Mortality in Individuals with Dementia: A Systematic Review and Meta‐Analysis , 2016, Journal of the American Geriatrics Society.
[41] M. Barcikowska,et al. Hypertension in patients with Alzheimer's disease--prevalence, characteristics, and impact on clinical outcome. Experience of one neurology center in Poland. , 2015, Journal of the American Society of Hypertension : JASH.
[42] Ronald C Petersen,et al. Multimorbidity and Risk of Mild Cognitive Impairment , 2015, Journal of the American Geriatrics Society.
[43] R. Petersen,et al. Risk and protective factors for cognitive impairment in persons aged 85 years and older , 2015, Neurology.
[44] Michael E. Miller,et al. The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2014, Diabetes Care.
[45] I. Rosset,et al. Global Epidemiology of Dementia: Alzheimer's and Vascular Types , 2014, BioMed research international.
[46] S. M. de la Monte,et al. Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.
[47] J. Williamson,et al. Albuminuria and cognitive decline in people with diabetes and normal renal function. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[48] Stephen Todd,et al. Survival in dementia and predictors of mortality: a review , 2013, International journal of geriatric psychiatry.
[49] E. Sampson,et al. Survival of people with dementia after unplanned acute hospital admission: a prospective cohort study , 2013, International journal of geriatric psychiatry.
[50] J. Semmens,et al. Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. , 2013, American journal of epidemiology.
[51] J. Mant,et al. Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000–2009 , 2012, Heart.
[52] I. Torres-Aleman,et al. The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.
[53] J. Leal,et al. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden? , 2012, European journal of neurology.
[54] Silvio Garattini,et al. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium , 2011, Journal of comorbidity.
[55] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[56] B. Winblad,et al. Diabetes, Alzheimer disease, and vascular dementia , 2010, Neurology.
[57] A. Levey,et al. Factors Affecting Survival of Patients with Neurodegenerative Disease , 2010, Neuroepidemiology.
[58] Y. Stern,et al. Survival in Alzheimer disease , 2008, Neurology.
[59] C. Bulpitt,et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.
[60] A. Blamire,et al. Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology , 2008, Hepatology.
[61] I. Poon. Effects of Antihypertensive Drug Treatment on the Risk of Dementia and Cognitive Impairment , 2008, Pharmacotherapy.
[62] G. Zielhuis,et al. Prognosis and vascular co-morbidity in dementia a historical cohort study in general practice , 2008, The journal of nutrition, health & aging.
[63] Jing Xie,et al. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up , 2008, BMJ : British Medical Journal.
[64] E. Tolosa,et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[65] Richard Mayeux,et al. Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.
[66] H. Tillmann,et al. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment , 2006, Gut.
[67] K Yaffe,et al. Frontotemporal dementia progresses to death faster than Alzheimer disease , 2005, Neurology.
[68] Werner Poewe,et al. How to diagnose dementia with Lewy bodies: State of the art , 2005, Movement disorders : official journal of the Movement Disorder Society.
[69] S. DeKosky,et al. Alzheimer disease and mortality: a 15-year epidemiological study. , 2005, Archives of neurology.
[70] H. Tillmann,et al. Hepatitis C virus infection and the brain , 2004, Metabolic Brain Disease.
[71] W. Kukull,et al. Survival after Initial Diagnosis of Alzheimer Disease , 2004, Annals of Internal Medicine.
[72] K. Schulman,et al. The Effect of Dementia on Outcomes and Process of Care for Medicare Beneficiaries Admitted with Acute Myocardial Infarction , 2004, Journal of the American Geriatrics Society.
[73] P. K. Gangopadhaya,et al. Parkinsonism plus syndrome--a review. , 2003, Neurology India.
[74] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[75] B Miller,et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.
[76] J. Allsop,et al. Evidence for a cerebral effect of the hepatitis C virus , 2001, The Lancet.
[77] T Ostbye,et al. A reevaluation of the duration of survival after the onset of dementia. , 2001, The New England journal of medicine.
[78] S. Weyerer,et al. Predictors of mortality among demented elderly in primary care , 1999, International journal of geriatric psychiatry.
[79] B. Winblad,et al. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. , 1999, Journal of clinical epidemiology.
[80] B. Winblad,et al. Prognostic Factors in Very Old Demented Adults: A Seven‐Year Follow‐Up From a Population‐Based Survey in Stockholm , 1998, Journal of the American Geriatrics Society.
[81] J. H. van der Meulen,et al. Comorbidity and Its Effect on Mortality in Nursing Home Patients with Dementia , 1996, The Journal of nervous and mental disease.
[82] C. Pieper,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV , 1996, Neurology.
[83] P. Mölsä,et al. Long‐term survival and predictors of mortality in Alzheimer's disease and multi‐infarct dementia , 1995, Acta neurologica Scandinavica.
[84] Amos D. Korczyn,et al. Vascular dementia , 1993, Journal of the Neurological Sciences.
[85] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[86] S. Monte. Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease , 2016, Drugs.
[87] P. Rabins,et al. Dementia , 2008, Annals of Internal Medicine.